Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 24,188 shares at $86.01 ($2.1M) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Open-market sale of $2.1M LGND by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.01 | 5,873 | $505K | 24.2% |
| 2 | $86.01 | 5,873 | $505K | 24.2% |
| 3 | $86.00 | 2,264 | $195K | 9.3% |
| 4 | $86.65 | 134 | $12K | 0.6% |
| 5 | $86.67 | 5,022 | $435K | 20.9% |
| 6 | $86.67 | 5,022 |
| $435K |
| 20.9% |
| Total | $86.29 avg | 24,188 | $2.1M | 100% |
| Filing → |
| LGND | SELL | 2026-03-06 | $5.5M | — | Filing → |
| LGND | SELL | 2025-12-16 | $679K | — | Filing → |
| LGND | BUY | 2025-05-13 | $156K | — | Filing → |